We found for
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers
![Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers](https://www.ohe.org/wp-content/uploads/2022/01/CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape.jpg)
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
![Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations](https://www.ohe.org/wp-content/uploads/2023/01/Healthcare-systems_AdobeStock_Rawpixel.com_landscape.jpg)
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
![It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?](https://www.ohe.org/wp-content/uploads/2022/02/Towse-Fenwick-post-review-final-v2-01.png)